Company: MHLA
Filing Date: 2025-03-20
Form Type: 10-K/A
Source: 0001412100-25-000020
Chunk: 20

Company: Maiden Holdings, Ltd.
Filing Date: 2025-03-20
Form: 10-K/A
Chunk 20
---
 for Mr. Jarman was $200,000.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| (7) |     | Represents the aggregate grant date fair market value of non-performance based restricted share awards granted to the named executive officer as determined in accordance with Accounting Standards Codification Topic No. 718, "Compensation Stock Discussion," using the assumptions described in Note 14 to the Financial Statements included in our Annual Report on Form 10-K filed with the SEC on March 10, 2025. At the discretion of the Compensation Committee on March 17, 2023, Mr. Jarman was granted 76,086 restricted shares, vesting 100% on March 31, 2025. The restricted shares were awarded with voting and dividend rights. The value of the restricted shares at grant date fair market value for Mr. Jarman was $175,000.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| (8) |     | All other compensation amounts disclosed reflect costs related to supplemental allowance and executive life insurance for all three named executive officers. For Mr. Haveron, these amounts also include tax equalization and Bermuda Social Insurance. For Mr. Metz, these amounts also include executive physical, tax equalization and Bermuda Social Insurance. For Mr. Jarman, these amounts also include an executive physical.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

<div align='center'>11</div>

#### OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END 2024
The following table sets forth the share awards held by named executive officers as of December 31, 2024. None of the named executive officers have any outstanding option awards as of December 31, 2024. The outstanding share awards are as follows:

|                    | Name | Share Awards |     |         |     |    | Number of Shares That Have Not Vested |     |    |           |     |   | Market Value of Shares That Have Not Vested |     |           |     |    | Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested |     |    |           |     |   | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested |
|:-------------------|:-----|:-------------|:----|--------:|:----|---:|--------------------------------------:|:----|---:|----------:|:----